Dear Sir, Please find the attached Postal Ballot Notice , Kindly take the note of the same.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Colinz Laboratories is seeking shareholder approval via postal ballot to sell two key assets: its pharmaceutical formulations factory at Sinnar, Nashik and its registered office premises at Pratik Estate, Mulund (Mumbai). The minimum reserve price for each asset is Rs. 3 crore, meaning total potential inflows of at least Rs. 6 crore on a slump sale basis. The company says the 1998-era factory would need heavy spending to comply with new Schedule M-WHO norms, making it cheaper to set up a new compliant unit (possibly in Gujarat). The 25-year-old Mumbai office also lacks basic facilities and cannot be redeveloped due to a nearby electric tower. E-voting runs from October 15 to November 14, 2025, with the cut-off date set as October 7, 2025.
If shareholders approve, the company will exit its existing manufacturing operations and registered office, which together represent core operational assets. This is a significant restructuring move — proceeds could fund a new WHO-compliant factory and reposition the business, but in the short term the company would lose its current production base.